For help on how to get the results you want, see our search tips.
1483 results
Medicine
Summaries of opinion Remove Summaries of opinion filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Cresemba (updated)
isavuconazole, Aspergillosis
Date of authorisation: 15/10/2015,
, Revision: 13, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Talzenna (updated)
talazoparib, Breast Neoplasms
Date of authorisation: 20/06/2019,
, Revision: 6, Authorised, Last updated: 07/12/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Vaxxitek HVT+IBD (updated)
Recombinant turkey herpesvirus, strain vhvt013-69, live, Embryonated eggs; Chicken
Date of authorisation: 09/08/2002, Revision: 16, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Komboglyze (updated)
metformin hydrochloride, saxagliptin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 24/11/2011, Revision: 18, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Vectibix (updated)
panitumumab, Colorectal Neoplasms
Date of authorisation: 03/12/2007, Revision: 33, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Efient (updated)
prasugrel, Acute Coronary Syndrome; Angina, Unstable; Myocardial Infarction
Date of authorisation: 24/02/2009, Revision: 23, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Miglustat Gen.Orph (updated)
miglustat, Gaucher Disease
Date of authorisation: 09/11/2017,
, Revision: 7, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Jardiance (updated)
empagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 22/05/2014, Revision: 23, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Lynparza (updated)
Olaparib, Ovarian Neoplasms
Date of authorisation: 16/12/2014, Revision: 17, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Mayzent (updated)
Siponimod fumaric acid, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 13/01/2020,, Revision: 6, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, 
, Revision: 15, Authorised, Last updated: 07/12/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Ubac (updated)
Lipoteichoic acid from Biofilm Adhesion Component of Streptococcus uberis, strain 5616, Cattle
Date of authorisation: 26/07/2018, Revision: 1, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Afinitor (updated)
everolimus, Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms
Date of authorisation: 02/08/2009, Revision: 29, Authorised, Last updated: 07/12/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Tulissin (updated)
tulathromycin, Cattle; Pigs; Sheep
Date of authorisation: 24/04/2020,, Revision: 3, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Noxafil (updated)
posaconazole, Candidiasis; Mycoses; Coccidioidomycosis; Aspergillosis
Date of authorisation: 25/10/2005, Revision: 30, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Multaq (updated)
dronedarone, Atrial Fibrillation
Date of authorisation: 25/11/2009, Revision: 16, Authorised, Last updated: 07/12/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Bravecto Plus (updated)
fluralaner, moxidectin, Cats
Date of authorisation: 08/05/2018, Revision: 8, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Mekinist (updated)
trametinib, Melanoma
Date of authorisation: 30/06/2014, Revision: 25, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Ninlaro (updated)
ixazomib citrate, Multiple Myeloma
Date of authorisation: 21/11/2016,, , , Revision: 12, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Dexmedetomidine Accord (updated)
dexmedetomidine, Premedication
Date of authorisation: 13/02/2020,, Revision: 2, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Enerzair Breezhaler (updated)
indacaterol, glycopyrronium bromide, mometasone, Asthma
Date of authorisation: 03/07/2020, Revision: 3, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Emgality (updated)
Galcanezumab, Migraine Disorders
Date of authorisation: 14/11/2018,, Revision: 7, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Rekambys (updated)
rilpivirine, HIV Infections
Date of authorisation: 17/12/2020,, Revision: 3, Authorised, Last updated: 07/12/2021
-
List item
Human medicine European public assessment report (EPAR): Pixuvri (updated)
pixantrone dimaleate, Lymphoma, Non-Hodgkin
Date of authorisation: 10/05/2012, Revision: 23, Authorised, Last updated: 07/12/2021 -
List item
Human medicine European public assessment report (EPAR): Vargatef (updated)
nintedanib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 21/11/2014, Revision: 17, Authorised, Last updated: 07/12/2021